FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

‘Tony’ is an annoying, unimpressive biopic of Anthony Bourdain

Texas Gov. Greg Abbott moves to cut state funding for AI-powered Flock cameras amid privacy concerns

WATCH: Wanted man escapes cops twice by running onto freeway, then walks into their Panda Express lunch

Nashville airport could be renamed in honor of Dolly Parton

NYC Judge Frees Man Accused of Shooting Service Dog of Woman with Down Syndrome While Attempting to Kill Man

Big Bend border wall construction pause extended to September

DOJ Arrests Honduran Man Accused of Taking Advantage of California’s Weak Election Laws

Bryan Kohberger seeks judge’s removal in escalating bid to undo guilty plea

At March on Washington, an urgent plea for black voters to turn out in the midterm elections

LGBTQ group reveals which Dem nominee is sponsoring Halloween event featuring drag shows

3-Time Pro-Bowl Running Back Josh Jacobs Is Facing Criminal Charges

Right-Wing Provocateur Milo Yiannopoulos Detained by ICE in Louisiana: Report

Appeals court denies Peter Navarro bid to rehear contempt challenge: ‘Always headed to Supreme Court’

State Dept. Revokes Visa of Iraqi Woman Who Received Award from Biden After She’s Found on Terror Watch List

Tennessee Governor Announces Plan to Rename Nashville Airport in Honor of Dolly Parton

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”